Financhill
Back

Inhibrx Biosciences, Inc. Vs. Seres Therapeutics, Inc. Industry Stock Comparison

Sell
42

INBX
Inhibrx Biosciences, Inc.

Last Price:
$78.82
Seasonality Move:
-1.59%
Sell
15

MCRB
Seres Therapeutics, Inc.

Last Price:
$14.85
Seasonality Move:
-11.78%
Sell
42
Inhibrx Biosciences, Inc. (INBX) is a Sell

Is Inhibrx Biosciences, Inc. a Buy, Sell or Hold?

  • The current Inhibrx Biosciences, Inc. [INBX] share price is $77.98. The Score for INBX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • INBX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Seres Therapeutics, Inc. (MCRB) is a Sell

Is Seres Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Seres Therapeutics, Inc. [MCRB] share price is $14.44. The Score for MCRB is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • MCRB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

INBX Stock Price Chart

What is Inhibrx Biosciences, Inc.'s stock price today?

  • The Inhibrx Biosciences, Inc. share price today is $77.98
    The current trend is moderately bearish and INBX is experiencing selling pressure, which indicates risk of future bearish movement.

MCRB Stock Price Chart

What is Seres Therapeutics, Inc.'s stock price today?

  • The Seres Therapeutics, Inc. share price today is $14.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.

INBX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.87 Buy
Relative Strength Index (14 RSI): 46.65 Sell
Chaikin Money Flow: -108837 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.18 - 87.12) Sell
Bollinger Bands (100): (26.78 - 78.74) Buy

MCRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.8 Sell
Relative Strength Index (14 RSI): 40.09 Sell
Chaikin Money Flow: -33292 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.18 - 17.34) Sell
Bollinger Bands (100): (15.28 - 20) Sell

INBX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 81.86 Sell
20-day SMA: 83.33 Sell
50-day SMA: 76.57 Buy
200-day SMA: 34.07 Buy
8-day EMA: 80.64 Sell
20-day EMA: 81.35 Sell
50-day EMA: 73.36 Buy
200-day EMA: 43.4 Buy

MCRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.9 Sell
20-day SMA: 16.02 Sell
50-day SMA: 16.86 Sell
200-day SMA: 14.14 Buy
8-day EMA: 15.03 Sell
20-day EMA: 15.85 Sell
50-day EMA: 16.69 Sell
200-day EMA: 16.14 Sell

Inhibrx Biosciences, Inc. Earnings Growth & INBX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.25 per share, and an increase next year of $2.01 per share.

Seres Therapeutics, Inc. Earnings Growth & MCRB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $4.48 per share, a decrease next quarter of $0.00 per share, a decrease this year of $11.20 per share, and a decrease next year of $1.03 per share.

Inhibrx Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Seres Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):